165 related articles for article (PubMed ID: 11322940)
1. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.
Yin D; Tang JG
FEBS Lett; 2001 Apr; 495(1-2):16-20. PubMed ID: 11322940
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular injection of naked plasmid DNA encoding human preproinsulin gene in streptozotocin-diabetes mice results in a significant reduction of blood glucose level.
Wang LY; Sun W; Chen MZ; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):641-7. PubMed ID: 14695479
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
Croze F; Prud'homme GJ
J Gene Med; 2003 May; 5(5):425-37. PubMed ID: 12731091
[TBL] [Abstract][Full Text] [Related]
4. Insulin delivery with plasmid DNA.
Abai AM; Hobart PM; Barnhart KM
Hum Gene Ther; 1999 Nov; 10(16):2637-49. PubMed ID: 10566891
[TBL] [Abstract][Full Text] [Related]
5. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
Lee RH; Roll G; Nguyen V; Willenbring H; Tang Q; Kang SM; Stock PG
Transplant Proc; 2014; 46(6):2002-6. PubMed ID: 25131094
[TBL] [Abstract][Full Text] [Related]
6. Naked plasmid-mediated gene transfer to skeletal muscle ameliorates diabetes mellitus.
Kon OL; Sivakumar S; Teoh KL; Lok SH; Long YC
J Gene Med; 1999; 1(3):186-94. PubMed ID: 10738567
[TBL] [Abstract][Full Text] [Related]
7. Mice body weight gain is prevented after naked human leptin cDNA transfer into skeletal muscle by electroporation.
Wang XD; Liu J; Yang JC; Chen WQ; Tang JG
J Gene Med; 2003 Nov; 5(11):966-76. PubMed ID: 14601134
[TBL] [Abstract][Full Text] [Related]
8. Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle.
Martinenghi S; Cusella De Angelis G; Biressi S; Amadio S; Bifari F; Roncarolo MG; Bordignon C; Falqui L
Gene Ther; 2002 Nov; 9(21):1429-37. PubMed ID: 12378405
[TBL] [Abstract][Full Text] [Related]
9. Reversal of diabetes in streptozotocin-treated rats by intramuscular injection of recombinant adeno-associated virus containing rat preproinsulin II gene.
Shah R; Sidner RA; Bochan MR; Jindal RM
Transplant Proc; 1999; 31(1-2):641-2. PubMed ID: 10083275
[No Abstract] [Full Text] [Related]
10. In vivo gene therapy of type I diabetic mellitus using a cationic emulsion containing an Epstein Barr Virus (EBV) based plasmid vector.
Yoo HS; Mazda O; Lee HY; Kim JC; Kwon SM; Lee JE; Kwon IC; Jeong H; Jeong YS; Jeong SY
J Control Release; 2006 May; 112(1):139-44. PubMed ID: 16530875
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated insulin gene transfer improves nutritional and post-hepatectomized conditions in diabetic rats.
Yamaguchi M; Kuzume M; Matsumoto T; Shimura H; Matsumiya A; Nakano H; Takeda M; Sanada Y; Kumada K
Surgery; 2000 Jun; 127(6):670-8. PubMed ID: 10840363
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated preproinsulin gene transfer into adipose tissues ameliorates hyperglycemia in obese diabetic KKA(y) mice.
Nagamatsu S; Nakamichi Y; Ohara-Imaizumi M; Ozawa S; Katahira H; Watanabe T; Ishida H
FEBS Lett; 2001 Nov; 509(1):106-10. PubMed ID: 11734215
[TBL] [Abstract][Full Text] [Related]
13. [Recombination of RegIII-proinsulin-pBudCE4.1 plasmid and its therapeutic effect on STZ-induced type 1 diabetes mellitus].
Hou WR; Xie SN; Lu JL; Xi W; Luo X; Xiang M
Yao Xue Xue Bao; 2010 Aug; 45(8):987-94. PubMed ID: 21351584
[TBL] [Abstract][Full Text] [Related]
14. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene.
Shah R; Jindal RM
Pancreatology; 2003; 3(5):422-8. PubMed ID: 14526153
[TBL] [Abstract][Full Text] [Related]
15. Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.
He CX; Shi D; Wu WJ; Ding YF; Feng DM; Lu B; Chen HM; Yao JH; Shen Q; Lu DR; Xue JL
World J Gastroenterol; 2004 Feb; 10(4):567-72. PubMed ID: 14966918
[TBL] [Abstract][Full Text] [Related]
16. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.
Park YM; Woo S; Lee GT; Ko JY; Lee Y; Zhao ZS; Kim HJ; Ahn CW; Cha BS; Kim KS; Park CW; Lee HC
J Gene Med; 2005 May; 7(5):621-9. PubMed ID: 15651056
[TBL] [Abstract][Full Text] [Related]
18. Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.
Riu E; Mas A; Ferre T; Pujol A; Gros L; Otaegui P; Montoliu L; Bosch F
Diabetes; 2002 Mar; 51(3):704-11. PubMed ID: 11872670
[TBL] [Abstract][Full Text] [Related]
19. Hepatic insulin expression improves glycemic control in type 1 diabetic rats.
Dong H; Morral N; McEvoy R; Meseck M; Thung SN; Woo SL
Diabetes Res Clin Pract; 2001 Jun; 52(3):153-63. PubMed ID: 11323084
[TBL] [Abstract][Full Text] [Related]
20. Intravascular insulin gene delivery as potential therapeutic intervention in diabetes mellitus.
Yasutomi K; Itokawa Y; Asada H; Kishida T; Cui FD; Ohashi S; Gojo S; Ueda Y; Kubo T; Yamagishi H; Imanishi J; Takeuchi T; Mazda O
Biochem Biophys Res Commun; 2003 Oct; 310(3):897-903. PubMed ID: 14550289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
